Conte-Devolx B, Grino M, Nieoullon A, Javoy-Agid F, Castanas E, Guillaume V, Tonon M C, Vaudry H, Oliver C
Neurosci Lett. 1985 May 14;56(2):217-22. doi: 10.1016/0304-3940(85)90132-6.
We have compared hypothalamic contents of various neurotransmitters (dopamine (DA), norepinephrine and serotonin) and their metabolites (dihydroxyphenyl acetic acid, homovanilic acid, 5-hydroxyindoleacetic acid) in post-mortem human controls and parkinsonian hypothalami. Neurotransmitters and their metabolites were measured in 0.1 N HCl hypothalami extracts using electrochemical detection after high performance liquid chromatography. Using specific radioimmunoassays we have also measured corticoliberin and somatocrinin contents in these hypothalami. Despite a 50% decrease of DA contents in parkinsonian hypothalami, no variations of corticoliberin and somatocrinin contents were found: 16.6 +/- 1.78 pg/mg tissue in Parkinson disease vs 16.71 +/- 1.89 in controls for human corticotropin-releasing factor (hCRF 1-41) and 37.38 +/- 11 vs 45.16 for human growth-hormone-releasing factor (hGRF 1-44).
我们比较了帕金森病患者下丘脑与正常对照者下丘脑内各种神经递质(多巴胺(DA)、去甲肾上腺素和5-羟色胺)及其代谢产物(二羟苯乙酸、高香草酸、5-羟吲哚乙酸)的含量。采用高效液相色谱结合电化学检测法,测定了0.1N盐酸下丘脑提取物中的神经递质及其代谢产物。我们还采用特异性放射免疫分析法测定了这些下丘脑内促肾上腺皮质激素释放素和生长激素释放素的含量。尽管帕金森病患者下丘脑内多巴胺含量降低了50%,但促肾上腺皮质激素释放素和生长激素释放素的含量并未发现变化:帕金森病患者促肾上腺皮质激素释放因子(hCRF 1-41)含量为16.6±1.78 pg/mg组织,正常对照者为16.71±1.89 pg/mg组织;生长激素释放因子(hGRF 1-44)含量在帕金森病患者中为37.38±11,正常对照者为45.16。